Javier Sanchez-Cespedes
Overview
Explore the profile of Javier Sanchez-Cespedes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
721
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Infante-Dominguez C, Salto-Alejandre S, Alvarez-Marin R, Sabe N, Ramos-Martinez A, Moreno A, et al.
Sci Rep
. 2024 Dec;
14(1):30021.
PMID: 39622951
Clinical phenotypes of COVID-19, associated with mortality risk, have been identified in the general population. The present study assesses their applicability in solid organ transplant recipients (SOTR) hospital-admitted by COVID-19....
2.
Ruiz-Molina A, Pech-Puch D, Millan R, Ageitos L, Villegas-Hernandez H, Pachon J, et al.
Chemistry
. 2024 Sep;
30(66):e202401844.
PMID: 39301783
Human Adenovirus (HAdV) infections in immunocompromised patients can result in disseminated diseases with high morbidity and mortality rates due to the absence of available treatments for these infections. The sponge...
3.
Ruiz-Arabi E, Torre-Cisneros J, Aguilera V, Alonso R, Berenguer M, Bestard O, et al.
Transplant Rev (Orlando)
. 2024 Aug;
38(4):100875.
PMID: 39168020
Cytomegalovirus (CMV) infection remains a significant challenge in solid organ transplantation (SOT). The last international consensus guidelines on the management of CMV in SOT were published in 2018, highlighting the...
4.
Martin-Escolano J, Salto-Alejandre S, Infante-Dominguez C, Carretero-Ledesma M, Maldonado-Lizarazo N, Camacho-Martinez P, et al.
Int J Infect Dis
. 2024 Jul;
146:107163.
PMID: 38969329
Objectives: Patients with haematologic malignancies (HM) COVID-19 have more severe disease, with increased risk of mortality. Therefore, this study aimed to evaluate the effect of SARS-CoV-2 RNAemia and the specific...
5.
Balsera-Manzanero M, Soengas R, Carretero-Ledesma M, Ratia C, Iglesias M, Pachon J, et al.
Heliyon
. 2024 Mar;
10(6):e27601.
PMID: 38545219
Despite the increasingly widespread clinical impact of adenovirus (HAdV) infections in healthy individuals and the associated high morbidity in immunosuppressed patients, particularly among the paediatric population, a specific treatment for...
6.
Carretero-Ledesma M, Aguilar-Guisado M, Berastegui-Cabrera J, Balsera-Manzanero M, Pachon J, Cordero E, et al.
Int J Antimicrob Agents
. 2024 Feb;
63(5):107116.
PMID: 38401774
Human adenovirus (HAdV) and cytomegalovirus (HCMV) cause high morbidity and mortality in patients undergoing solid organ transplantation (SOT) and haematopoietic stem cell transplantation (HSCT). Immunosuppressors are used universally to prevent...
7.
Balsera-Manzanero M, Ghirga F, Ruiz-Molina A, Mori M, Pachon J, Botta B, et al.
Front Pharmacol
. 2024 Jan;
14:1293296.
PMID: 38273842
Regardless of the clinical impact of human adenovirus (HAdV) infections in the healthy population and its high morbidity in immunosuppressed patients, a specific treatment is still not yet available. In...
8.
Aydillo T, Balsera-Manzanero M, Rojo-Fernandez A, Escalera A, Salamanca-Rivera C, Pachon J, et al.
Emerg Microbes Infect
. 2023 Dec;
13(1):2292068.
PMID: 38054302
Current clinical guidelines support the concomitant administration of seasonal influenza vaccines and COVID-19 mRNA boosters vaccine. Whether dual vaccination may impact vaccine immunogenicity due to an interference between influenza or...
9.
Herrera S, Aguado J, Candel F, Cordero E, Dominguez-Gil B, Fernandez-Ruiz M, et al.
Transplant Rev (Orlando)
. 2023 Aug;
37(4):100788.
PMID: 37591117
No abstract available.
10.
Mombelli M, Neofytos D, Huynh-Do U, Sanchez-Cespedes J, Stampf S, Golshayan D, et al.
Clin Infect Dis
. 2023 Aug;
78(1):48-56.
PMID: 37584344
Background: The immunogenicity of the standard influenza vaccine is reduced in solid-organ transplant (SOT) recipients, so new vaccination strategies are needed in this population. Methods: Adult SOT recipients from 9...